Show simple item record

dc.contributor.authorKvinge, Alexander Dåtland
dc.contributor.authorKvammen, Tobias
dc.contributor.authorMiletic, Hrvoje
dc.contributor.authorBindoff, Laurence Albert
dc.contributor.authorReikvam, Håkon
dc.date.accessioned2022-12-19T13:42:38Z
dc.date.available2022-12-19T13:42:38Z
dc.date.created2022-12-05T09:17:49Z
dc.date.issued2022
dc.identifier.issn1198-0052
dc.identifier.urihttps://hdl.handle.net/11250/3038596
dc.description.abstractMusculoskeletal graft versus host disease (GVHD) is a rare manifestation of chronic GVHD (cGVHD) following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Left untreated, the disease can cause extensive damage to muscle tissue and joints. We describe a 62-year-old male with musculoskeletal GVHD and generalized muscle pain and stiffness. In addition, we performed a systemic literature review based on published cases of musculoskeletal GVHD between 1983 and 2019. We identified 85 cases, 62% male and 38% female with an age of 4–69 years and median age of 39 years at diagnosis. The majority of patients (72%) also had manifestations of cGVHD in at least one other organ system, most frequently the skin (52%), followed by oropharyngeal mucosa (37%), and pulmonary and gastrointestinal tract (GI tract) (21%). We conclude that, while musculoskeletal cGVHD is a rare complication of allo-HSCT, it remains a serious and debilitating risk that must be considered in patients with muscle pain, muscle weakness, joint stiffness, and tissue inflammation. Early intervention is critical for the patient’s prognosis.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleMusculoskeletal Chronic Graft versus Host Disease-A Rare Complication to Allogeneic Hematopoietic Stem Cell Transplant: A Case-Based Report and Review of the Literatureen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.3390/curroncol29110663
dc.identifier.cristin2088441
dc.source.journalCurrent Oncologyen_US
dc.source.pagenumber8415-8430en_US
dc.identifier.citationCurrent Oncology. 2022, 29 (11), 8415-8430.en_US
dc.source.volume29en_US
dc.source.issue11en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal